NASDAQ:RCEL AVITA Medical (RCEL) Stock Price, News & Analysis $8.84 -0.06 (-0.67%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$8.75▼$8.9350-Day Range$7.72▼$10.4052-Week Range$7.51▼$18.93Volume93,175 shsAverage Volume206,664 shsMarket Capitalization$228.07 millionP/E RatioN/ADividend YieldN/APrice Target$15.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get AVITA Medical alerts: Email Address AVITA Medical MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside69.7% Upside$15.00 Price TargetShort InterestHealthy6.58% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($2.16) to ($1.25) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.84 out of 5 starsMedical Sector805th out of 910 stocksSurgical & Medical Instruments Industry89th out of 95 stocks 3.2 Analyst's Opinion Consensus RatingAVITA Medical has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageAVITA Medical has only been the subject of 1 research reports in the past 90 days.Read more about AVITA Medical's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted6.58% of the float of AVITA Medical has been sold short.Short Interest Ratio / Days to CoverAVITA Medical has a short interest ratio ("days to cover") of 8.Change versus previous monthShort interest in AVITA Medical has recently decreased by 12.90%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAVITA Medical does not currently pay a dividend.Dividend GrowthAVITA Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for RCEL. Previous Next 0.6 News and Social Media Coverage Search Interest2 people have searched for RCEL on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added AVITA Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, AVITA Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.82% of the stock of AVITA Medical is held by insiders.Percentage Held by InstitutionsOnly 27.66% of the stock of AVITA Medical is held by institutions.Read more about AVITA Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for AVITA Medical are expected to grow in the coming year, from ($2.16) to ($1.25) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of AVITA Medical is -5.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of AVITA Medical is -5.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAVITA Medical has a P/B Ratio of 9.61. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about AVITA Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. About AVITA Medical Stock (NASDAQ:RCEL)AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.Read More RCEL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RCEL Stock News HeadlinesAugust 30, 2024 | msn.comAVITA Medical Inc (NASDAQ:RCEL) A Bull Case TheoryAugust 28, 2024 | americanbankingnews.comReviewing AVITA Medical (NASDAQ:RCEL) and RenovaCare (OTCMKTS:RCAR)September 7, 2024 | Weiss Ratings (Ad)“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.August 23, 2024 | markets.businessinsider.comTD Cowen Sticks to Its Buy Rating for Avita Medical (RCEL)August 10, 2024 | finance.yahoo.comAVITA Medical Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsAugust 8, 2024 | investorplace.comRCEL Stock Earnings: AVITA Medical Misses EPS, Beats Revenue for Q2 2024August 8, 2024 | globenewswire.comAVITA Medical to Host Investor Webinar BriefingAugust 8, 2024 | globenewswire.comAVITA Medical Reports Second Quarter Financial ResultsSeptember 7, 2024 | Weiss Ratings (Ad)“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.August 4, 2024 | ca.finance.yahoo.comSNN Aug 2024 30.000 putJuly 31, 2024 | stockhouse.comAVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound CareJuly 11, 2024 | globenewswire.comAVITA Medical to Announce Second Quarter 2024 Financial ResultsJuly 1, 2024 | globenewswire.comAVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate SecretaryJune 5, 2024 | globenewswire.comAVITA Medical Achieves Milestone with First Case Using RECELL GOMay 30, 2024 | globenewswire.comAVITA Medical Announces FDA Approval of RECELL GOMay 16, 2024 | globenewswire.comAVITA Medical to Host Investor Webinar BriefingMay 15, 2024 | msn.comPiper Sandler Downgrades AVITA Medical (RCEL)May 14, 2024 | markets.businessinsider.comPiper Sandler Reaffirms Their Hold Rating on Avita Medical (RCEL)See More Headlines Receive RCEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AVITA Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/08/2024Today9/07/2024Next Earnings (Estimated)11/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:RCEL CUSIPN/A CIK1762303 Webwww.avitamedical.com Phone(833) 462-8482FaxN/AEmployees130Year Founded2008Price Target and Rating Average Stock Price Target$15.00 High Stock Price Target$21.00 Low Stock Price Target$9.00 Potential Upside/Downside+69.7%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($1.76) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-35,380,000.00 Net Margins-92.04% Pretax Margin-91.88% Return on Equity-118.27% Return on Assets-52.75% Debt Debt-to-Equity Ratio1.71 Current Ratio5.29 Quick Ratio4.81 Sales & Book Value Annual Sales$54.14 million Price / Sales4.21 Cash FlowN/A Price / Cash FlowN/A Book Value$0.92 per share Price / Book9.61Miscellaneous Outstanding Shares25,800,000Free Float25,330,000Market Cap$228.07 million OptionableOptionable Beta1.54 Social Links Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. James M. Corbett (Age 66)CEO, President & Executive Director Comp: $1.16MMr. David O'Toole (Age 65)Chief Financial Officer Comp: $574.64kMs. Donna Shiroma (Age 61)General Counsel, Chief Compliance Officer & Secretary Comp: $688.6kMr. David FencilSenior Vice President of Global OperationsDr. Katie Bush Ph.D.Senior Vice President of Scientific & Medical AffairsMs. Jessica EkebergInvestor Relations ExecutiveMs. Debbie GarnerSenior Vice President of Global Marketing & StrategyMr. Rob HallSenior Vice President of Human ResourcesMr. Terry BromleySenior Vice President of Global SalesDr. Niraj Doshi J.D.P.M.P., Ph.D., Senior Vice President of Product Development & Program ManagementMore ExecutivesKey CompetitorsPerspective TherapeuticsNYSE:CATXNational VisionNASDAQ:EYEBioventusNYSE:BVSOrthoPediatricsNASDAQ:KIDSLiquidiaNASDAQ:LQDAView All CompetitorsInsiders & InstitutionsAQR Capital Management LLCSold 67,535 shares on 8/15/2024Ownership: 0.089%The Manufacturers Life Insurance Company Bought 10,838 shares on 8/15/2024Ownership: 0.042%Dimensional Fund Advisors LPSold 22,804 shares on 8/9/2024Ownership: 0.088%Rhumbline AdvisersBought 4,463 shares on 8/1/2024Ownership: 0.142%Bank of New York Mellon CorpSold 34,919 shares on 7/26/2024Ownership: 0.282%View All Insider TransactionsView All Institutional Transactions RCEL Stock Analysis - Frequently Asked Questions How have RCEL shares performed this year? AVITA Medical's stock was trading at $13.72 at the beginning of the year. Since then, RCEL shares have decreased by 35.6% and is now trading at $8.84. View the best growth stocks for 2024 here. How were AVITA Medical's earnings last quarter? AVITA Medical, Inc. (NASDAQ:RCEL) posted its quarterly earnings results on Thursday, August, 8th. The company reported ($0.60) EPS for the quarter, missing the consensus estimate of ($0.59) by $0.01. The firm had revenue of $15.20 million for the quarter, compared to analyst estimates of $15.04 million. AVITA Medical had a negative net margin of 92.04% and a negative trailing twelve-month return on equity of 118.27%. Who are AVITA Medical's major shareholders? Top institutional investors of AVITA Medical include Bank of New York Mellon Corp (0.28%), Rhumbline Advisers (0.14%), AQR Capital Management LLC (0.09%) and Dimensional Fund Advisors LP (0.09%). Insiders that own company stock include Michael S Perry, Donna Shiroma, Jeremy Curnock Cook, James Corbett and Suzanne Crowe. View institutional ownership trends. How do I buy shares of AVITA Medical? Shares of RCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of AVITA Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that AVITA Medical investors own include NVIDIA (NVDA), Block (SQ), Alibaba Group (BABA), Micron Technology (MU), Netflix (NFLX), PayPal (PYPL) and Twilio (TWLO). This page (NASDAQ:RCEL) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVITA Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AVITA Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
